Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hsieh MH, Chen SA.
------>authors3_c=None
------>paper_class1=4
------>Impact_Factor=None
------>paper_class3=0
------>paper_class2=0
------>vol=
------>confirm_bywho=tzengcr
------>insert_bywho=mhhsieh
------>Jurnal_Rank=None
------>authors4_c=None
------>comm_author=
------>patent_EDate=None
------>authors5_c=None
------>publish_day=None
------>paper_class2Letter=None
------>page2=203
------>medlineContent=
------>unit=E0100
------>insert_date=20030428
------>iam=1
------>update_date=
------>author=???
------>change_event=5
------>ISSN=None
------>authors_c=None
------>score=171
------>journal_name=Catheter ablation of arrhythmias
------>paper_name=Catheter ablation of focal atrial tachycardia.
------>confirm_date=20030429
------>tch_id=089018
------>pmid=19920360
------>page1=185
------>fullAbstract=Background: Atrial tachycardia (AT) is sometimes difficult to eliminate by radiofrequency ablation (RFA), but the EnSite array (EA) visualizes the beat-to-beat virtual activation of any tachycardia. Methods and Results: The 51 patients with 74 ATs (mean age 57+/-18 years, 28 males) undergoing EA-guided RFA were included; 14 patients had had previous open heart surgery and 5 had organic heart disease. RFA was performed at the AT focus for focal AT (n=48) with an endpoint of AT termination and subsequent non-inducibility. RFA was performed at a critical conducting pathway for reentrant AT (n=26) with creation of a block line in the critical reentry circuit. EA revealed that 57 ATs originated in the right atrium (77%) and 17 originated in the left atrium (23%); all but 1 were successfully eliminated. Fluoroscopic time was 19+/-11 min, the number of RFA applications was 8+/-7, and the radiofrequency energy was 10,711+/-12,655 J. No complications were noted. All but 2 patients were free of any symptoms during a follow-up of 16+/-9 months. Conclusions: EA-guided RFA is safe and effective for AT, irrespective of its mechanism, sustainability or origin, and regardless of underlying heart disease.
------>tmu_sno=None
------>sno=7159
------>authors2=None
------>authors3=None
------>authors4=None
------>authors5=None
------>authors6=None
------>authors6_c=None
------>authors=Hsieh MH, Chen SA.
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=None
------>publish_area=None
------>updateTitle=Radiofrequency Catheter Ablation of Atrial Tachycardia Under Navigation Using the EnSite Array.
------>language=2
------>check_flag=
------>submit_date=
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=
------>publish_year=2002
------>submit_flag=
------>publish_month=None
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z